Oral Anticoagulation versus Antiplatelet Treatment after Mitral Valve Repair: a Systematic Review and Meta-Analysis

Oral anticoagulation with vitamin K antagonists (VKA) is currently advised for a period of three months following surgical mitral valve repair, regardless of the rhythm status. The evidence supporting this recommendation is weak and recent studies have challenged the safety and efficacy of this reco...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2024-01, Vol.210, p.58-64
Hauptverfasser:	Tomšič, Anton, Zhao, Chengji, Schoones, Jan W., Klautz, Robert J.M., Palmen, Meindert
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Antagonists Anticoagulants Aspirin Bias Bleeding Bleeding complications Cardiac arrhythmia Complications Effectiveness Hemorrhage - chemically induced Humans Ischemia Literature reviews Meta-analysis Mitral valve Mitral Valve - surgery Mortality Oral anticoagulation Patients Performance evaluation Perioperative care Phylloquinone Risk Safety Surgery Systematic review Thoracic surgery Thromboembolic complications Thromboembolism Thromboembolism - epidemiology Thromboembolism - etiology Thromboembolism - prevention & control Vitamin K
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!